Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety.
Saved in:
| Title: | Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety. |
|---|---|
| Authors: | Tang, Ansel Shao Pin1 (AUTHOR), Hsu, Jovan Teng Yuan1 (AUTHOR), Chong, Sheena Kar Shuan1 (AUTHOR), Quek, Jingxuan1 (AUTHOR), Shek, Genevieve2 (AUTHOR), Sulaimi, Farisah2 (AUTHOR), Chan, Kai En1 (AUTHOR), Anand, Vickram Vijay3 (AUTHOR), Chong, Bryan1 (AUTHOR), Mehta, Anurag4 (AUTHOR), Toh, Sue-Anne1,5,6,7 (AUTHOR), Muthiah, Mark8,9 (AUTHOR), Dimitriadis, Georgios K.10,11 (AUTHOR), le Roux, Carel W.12,13 (AUTHOR), Chan, Mark Yan-Yee1,14 (AUTHOR), Mamas, Mamas Andreas15 (AUTHOR), Chin, Yip Han16 (AUTHOR), Chew, Nicholas W. S.1,14 (AUTHOR) Nicholas_WS_Chew@nuhs.edu.sg |
| Source: | Cardiovascular Diabetology. 7/12/2025, Vol. 24 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14752840 |
|---|---|
| DOI: | 10.1186/s12933-025-02840-3 |
